STAAR Surgical notches regulatory milestones for its Visian Implantable Collamer Lenses, landing a rescheduled date with a panel of FDA advisors and winning Japanese approval for a new model.
Arrhythmia Research Technologies and Blue Belt Technologies ink a supply deal for components used in Blue Belt's Stride knee implant.
Arrhythmia Research Technology (NYSE:HRT) subsidiary Micron Products said it inked a deal to supply components for Blue Belt Technologies' Stride unicondylar knee implant system.
RTI Surgical subsidiary Pioneer Surgical Technology renews a supply deal with Zimmer's trauma division.
Smith & Nephew introduces its Polarstem cementless total hip replacement stem to the American market.
Smith & Nephew (FTSE:SN, NYSE:SNN) said it's launching its Polarstem cementless hip stem in the United States for total hip replacement procedures.
Aurora Spine secures 510(k) clearance from the FDA for its TiNano implants for spinal fusion procedures.
Aurora Spine (TSX:ASG.V) said it won 510(k) clearance from the FDA for its TiNano coated interbody systems for spinal fusion procedures.
Ellipse Technologies wins 510(k) clearance from the FDA for its Precice 2 limb-lengthening system.
Ellipse Technologies said it secured clearance from the FDA for its Precice 2 limb-lengthening system.
Irvine, Calif.-based Ellipse makes spinal and orthopedic devices. The devices are adjustable without an invasive procedure and mainly come in the form of remote-controlled implants.
Second Sight Medical announces the 1st post-approval, U.S. implants of the Argus II retinal prosthesis, designed to help restore sight to patients with blindness as a result of retinitis pigmentosa.
Updated Jan. 29, 2014, at 11:10 a.m. with comment from Second Sight Medical.
Second Sight Medical today announced the 1st commercial U.S. implants of its Argus II bionic eye system, which won FDA approval about a year ago.